Immunology Today—June 3, 2026
This week’s Immunology update highlights regulatory and clinical developments…
Cell and Gene Therapy Today—May 28, 2026
This week’s Gene and Cell Therapy update highlights regulatory progress, gene…
Immunology Today—May 20, 2026
This week’s Immunology update highlights regulatory and clinical developments…
Cell and Gene Therapy Today—May 14, 2026
This week’s Gene and Cell Therapy update highlights regulatory updates,…
Oncology Today—May 11, 2026
This week’s Oncology update highlights regulatory progress, late-stage clinical…
Oncology Today—April 20, 2026
This week’s Oncology update highlights regulatory progress, pivotal clinical…
Oncology Today—April 14, 2026
This week’s Oncology update highlights regulatory progress, pivotal clinical…
Rare Diseases Today—April 9, 2026
This week’s Rare Diseases update highlights regulatory momentum, late-stage…
Oncology Today—April 6, 2026
This week’s Oncology update highlights regulatory progress, late-stage clinical…
Oncology Today—March 9, 2026
This week’s Oncology update highlights regulatory approvals, reimbursement…
Oncology Today—February 9, 2026
This week's Oncology update , covers regulatory actions, late-stage clinical…
Lucid Diligence Brief: AstraZeneca buys remaining China rights to AbelZeta’s GPC3-armored CAR-T
Lucid Diligence Brief: AstraZeneca buys remaining China rights to AbelZeta’s…
